Please use this identifier to cite or link to this item: https://doi.org/10.18632/oncotarget.14606
Title: A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
Authors: Dai X.
Wang L. 
Deivasigamni A.
Looi C.Y.
Karthikeyan C.
Trivedi P.
Chinnathambi A.
Alharbi S.A.
Arfuso F.
Dharmarajan A.
Goh B.C. 
Hui K.M. 
Kumar A.P. 
Mustafa M.R.
Sethi G. 
Keywords: acetylcysteine
benzimidazole derivative
caspase 3
methyl 2 (5 fluoro 2 hydroxyphenyl) 1h benzo[d]imidazole 5 carboxylate
reactive oxygen metabolite
stress activated protein kinase
unclassified drug
animal experiment
animal model
animal tissue
antineoplastic activity
apoptosis
Article
cancer inhibition
cell invasion
cell migration
cell viability
controlled study
female
flow cytometry
human
human cell
liver cell carcinoma
mitochondrion
mouse
nonhuman
signal transduction
Western blotting
Issue Date: 2017
Citation: Dai X., Wang L., Deivasigamni A., Looi C.Y., Karthikeyan C., Trivedi P., Chinnathambi A., Alharbi S.A., Arfuso F., Dharmarajan A., Goh B.C., Hui K.M., Kumar A.P., Mustafa M.R., Sethi G. (2017). A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma. Oncotarget 8 (8) : 12831-12842. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.14606
Abstract: A prior screening programme carried out using MTT assay by our group identified a series of novel benzimidazole derivatives, among which Methyl 2-(5-fluoro-2- hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) showed highest anticancer efficacy compared to that of chemotherapeutic agent, cisplatin. In the present study, we found that MBIC inhibited cell viability in different hepatocellular carcinoma (HCC) cell lines without exerting significant cytotoxic effects on normal liver cells. Annexin V-FITC/PI flow cytometry analysis and Western blotting results indicated that MBIC can induce apoptosis in HCC cells, which was found to be mediated through mitochondria associated proteins ultimately leading to the activation of caspase-3. The exposure to MBIC also resulted in remarkable impairment of HCC cell migration and invasion. In addition, treatment with MBIC led to a rapid generation of reactive oxygen species (ROS) and substantial activation of c-Jun-N-terminal kinase (JNK). The depletion of ROS by N-Acetyl cysteine (NAC) partially blocked MBIC-induced apoptosis and JNK activation in HCC cells. Finally, MBIC significantly inhibited tumor growth at a dose of 25 mg/kg in an orthotopic HCC mouse model. Taken together, these results demonstrate that MBIC may inhibit cell proliferation via ROS-mediated activation of the JNK signaling cascade in HCC cells.
Source Title: Oncotarget
URI: https://scholarbank.nus.edu.sg/handle/10635/173807
ISSN: 19492553
DOI: 10.18632/oncotarget.14606
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_18632_oncotarget_14606.pdf3.48 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

30
checked on Mar 3, 2021

Page view(s)

64
checked on Mar 5, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.